| Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas FC Geyer, B Weigelt, R Natrajan, MBK Lambros, D de Biase, R Vatcheva, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 199 | 2010 |
| Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping R Trisolini, A Cancellieri, C Tinelli, D De Biase, I Valentini, G Casadei, ... Chest 148 (6), 1430-1437, 2015 | 99 | 2015 |
| aPKC ζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia D Grifoni, F Garoia, P Bellosta, F Parisi, D De Biase, G Collina, D Strand, ... Oncogene 26 (40), 5960-5965, 2007 | 97 | 2007 |
| Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III M Visani, D De Biase, G Marucci, S Cerasoli, E Nigrisoli, MLB Reggiani, ... Molecular oncology 8 (2), 417-430, 2014 | 90 | 2014 |
| Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy) D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ... PloS one 8 (12), e83607, 2013 | 83 | 2013 |
| TERT promoter mutations in papillary thyroid microcarcinomas D De Biase, G Gandolfi, M Ragazzi, M Eszlinger, V Sancisi, M Gugnoni, ... Thyroid 25 (9), 1013-1019, 2015 | 82 | 2015 |
| Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas S Asioli, A Righi, D De Biase, L Morandi, V Caliendo, F Picciotto, ... Modern Pathology 24 (11), 1451-1461, 2011 | 75 | 2011 |
| Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review S Fiorino, L Bacchi-Reggiani, D De Biase, A Fornelli, M Masetti, A Tura, ... World journal of gastroenterology 21 (45), 12896, 2015 | 73 | 2015 |
| Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions D de Biase, M Visani, P Baccarini, AM Polifemo, A Maimone, A Fornelli, ... PloS one 9 (2), e87651, 2014 | 70 | 2014 |
| High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary … D De Biase, V Cesari, M Visani, GP Casadei, N Cremonini, G Gandolfi, ... The Journal of Clinical Endocrinology & Metabolism 99 (8), E1530-E1538, 2014 | 67 | 2014 |
| Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance G Acquaviva, M Visani, A Repaci, KJ Rhoden, D de Biase, A Pession, ... Histopathology 72 (1), 6-31, 2018 | 66 | 2018 |
| Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment S Moretti, E Menicali, P Voce, S Morelli, S Cantarelli, M Sponziello, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E832-E840, 2014 | 66 | 2014 |
| Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation L Morandi, D De Biase, M Visani, V Cesari, G De Maglio, S Pizzolitto, ... PloS one 7 (4), e36084, 2012 | 64 | 2012 |
| Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis S Piana, M Ragazzi, G Tallini, D De Biase, A Ciarrocchi, A Frasoldati, ... Human pathology 44 (4), 556-565, 2013 | 63 | 2013 |
| MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma S Fiorino, ML Bacchi-Reggiani, M Visani, G Acquaviva, A Fornelli, ... World journal of gastroenterology 22 (15), 3907, 2016 | 61 | 2016 |
| 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded … A Altimari, D de Biase, G De Maglio, E Gruppioni, E Capizzi, ... OncoTargets and therapy 6, 1057, 2013 | 61 | 2013 |
| Role of microRNAs in the main molecular pathways of hepatocellular carcinoma F Vasuri, M Visani, G Acquaviva, T Brand, M Fiorentino, A Pession, ... World journal of gastroenterology 24 (25), 2647, 2018 | 50 | 2018 |
| Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications AA Brandes, E Franceschi, A Paccapelo, G Tallini, D De Biase, ... The oncologist 22 (4), 432, 2017 | 48 | 2017 |
| BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study G Tallini, D De Biase, C Durante, G Acquaviva, M Bisceglia, R Bruno, ... Modern Pathology 28 (10), 1343-1359, 2015 | 47 | 2015 |
| E‐cadherin loss and ΔNp73L expression in oral squamous cell carcinomas showing aggressive behavior MP Foschini, R Cocchi, L Morandi, G Marucci, MG Pennesi, A Righi, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2008 | 43 | 2008 |
Michela VisaniUniversità di BolognaVerified email at unibo.it
